| umls-concept:C0046056 | skos:definition | NCI: The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.,NCI: A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04),PDQ: A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42609&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42609&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C964" NCI Thesaurus),MSH: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the a | lld:umls |
